EnQuest PLC Director notification

RNS Number : 2314H

EnQuest PLC

07 October 2024

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	The Amjad & Suha Bseisu Foundation
2	Reason for the notification
a)	Position/status	The Amjad & Suha Bseisu Foundation is a registered charity, of which Amjad Bseisu (CEO of EnQuest PLC)  is a Trustee
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	EnQuest PLC
b)	LEI	2138008LJU6WFQWOXJ73
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	EnQuest PLC GBP 9.00 per cent. Notes due 27 October 2027
	Identification code	XS2461853793
b)	Nature of the transaction	Disposal of 368,773 EnQuest PLC GBP 9.00 per cent. Notes due 27 October 2027.   The Trustees of the Amjad & Suha Bseisu Foundation have delegated all activities relating to EnQuest securities to the Chief Investment Officer of the Foundation and have no control over any decision made.
c)	Price(s) and volume(s)
			Price	Volume(s)
			95.4	368,773
d)	Aggregated information   - Aggregated volume - Price	n/a
e)	Date of the transaction	4 October 2024
f)	Place of the transaction	XLON

 

Ends

For further information please contact:

EnQuest PLC                                                                                                                  Tel: [phone]

Kate Christ

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHQKOBQQBDDBKK